CTOs on the Move

Revolution Medicines

www.revmed.com

 
REVOLUTION Medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. Our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. We pay particular attention to natural products that are inherently rich with biological function as a result of natural selection and can inform and guide our discovery and development of small molecules that can modulate these targets.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.revmed.com
  • 700 Saginaw Drive
    Redwood City, CA USA 94063
  • Phone: 650.481.6801

Executives

Name Title Contact Details
Sapan Shenoy
Senior Director Information Technology Profile
Anthony Mancini
EVP & Chief Operating Officer Profile

Funding

Revolution Medicines raised $260.9M on 02/03/2021

Similar Companies

20/20 GeneSystems Inc

20/20 GeneSystems Inc is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Emalex Biosciences

Developing new treatments for rare and orphan neurological conditions.

MeMed

MeMed is a host response, med-tech & bioconvergence company, offering innovative diagnostic host response tests that address complex clinical dilemmas & improve patient outcomes.

Ankyra Therapeutics

Ankyra is developing cancer therapies based on localized cytokines that prime a systemic adaptive immune response.

ProteinOne

ProteinOne is a Derwood, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.